Skip to main content

Table 1 Patients and surgery characteristics

From: A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetron on postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron

 

Group A (n = 41)

Group B (n = 44)

Group C (n = 42)

P value

Age (yr)

49 (21–65)

48 (27–65)

53 (23–64)

0.677

Weight (kg)

62 ± 11

62 ± 11

63 ± 11

0.894

Height (cm)

162 ± 8

163 ± 8

163 ± 9

0.728

Gender (M/F)

14/27

19/25

13/29

0.471

Preoperative dexamethasone

17 (41)

15 (34)

11 (26)

0.339

Operation time (min)

249 ± 87

288 ± 117

254 ± 110

0.179

Anesthesia time (min)

321 ± 90

368 ± 131

327 ± 114

0.110

 Type of surgery

   

0.322

 Tumor surgery

26 (63)

26 (59)

20 (48)

 

Vascular surgery

15 (37)

18 (41)

22 (52)

 

ASA class I/II

24 (59)/17 (41)

22 (50)/22 (50)

22 (52)/20 (48)

0.720

Preexisting disease, (n)

    

  Hypertension

11

13

13

0.916

  Diabetes mellitus

4

5

7

0.609

  Liver disease

3

2

0

0.223

  1. Group A; ondansetron 4 mg group. Group B; ondansetron 8 mg group. Group C; ramosetron 0.3 mg group. Values are expressed as mean (SD) or number of the patients (n) except age (mean, range).